For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Hyseq, Inc.

USPTO Granted Patents = 37

% Expired Patents = 2.7

Forward Citations = 2,466

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Radoje Drmanac (16 out of 134 patents)

John E Ford (12 out of 18 patents)

Ann Pace (6 out of 6 patents)

4. Radomir B Crkvenjakov (6 out of 9 patents)

5. George Yeung (5 out of 25 patents)

6. Julio Mulero (4 out of 15 patents)

7. Y Tom Tang (4 out of 92 patents)

8. Dennis G Ballinger (4 out of 12 patents)

9. Joerg Baier (4 out of 4 patents)

10. Chenghua Liu (3 out of 17 patents)

11. Alice Suk-Yue Ho (3 out of 3 patents)

12. Bryan J Boyle (2 out of 10 patents)

13. Nancy K Mize (2 out of 11 patents)

14. Matthew C Arterburn (2 out of 6 patents)

15. Ping Zhou (2 out of 4 patents)

Core Competencies:

Polypeptides

Nucleic Acids

IL-1 Receptor Antagonist

Growth Factor Antagonist

CD39-Like Polypeptides

DNA Sequencing

Hybridization

Biological Compounds

Assays

Recombinant Production

37 patents: Sort by Forward Citations

1. 6586390 - Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides (2003-07-01),

2. 6569662 - Nucleic acids and polypeptides (2003-05-27),

3. 6541623 - Interleukin—1 receptor antagonist and uses thereof (2003-04-01),

4. 6497870 - Therapeutic uses of il-1 receptor antagonist (2002-12-24),

5. 6485920 - Growth factor antagonist materials and methods (2002-11-26),

6. 6476211 - Methods and materials relating to CD39-like polypeptides (2002-11-05),

7. 6472173 - Chemokine receptor obtained from a cDNA library of fetal liver-spleen (2002-10-29),

8. 6465620 - Methods and materials relating to novel von Willebrand/Thrombospondin-like polypeptides and polynucleotides (2002-10-15),

9. 6447771 - Methods and materials relating to novel CD39-like polypeptides (2002-09-10),

10. 6436703 - Nucleic acids and polypeptides (2002-08-20),

11. 6426191 - Assays involving an IL-1 receptor antagonist (2002-07-30),

12. 6423682 - Sprouty related growth factor antagonist (FGFAn-Hy) materials and methods (2002-07-23),

13. 6403315 - Method and apparatus for DNA sequencing and DNA identification (2002-06-11),

14. 6392018 - EGF MOTIF protein obtained from a cDNA library of fetal liver-spleen (2002-05-21),

15. 6387645 - Methods and materials relating to novel CD39-like polypeptides (2002-05-14),

Company Overview

Hyseq, Inc. is a biotechnology company based in Sunnyvale, California, specializing in the development of innovative solutions for genomic analysis and molecular diagnostics. The organization focuses on advancing technologies that enhance the understanding of genetic information, thereby contributing to personalized medicine and improved healthcare outcomes. Hyseq's expertise encompasses a range of applications, including DNA sequencing and bioinformatics, positioning it as a key player in the rapidly evolving life sciences sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

37 Patents

#120 in Sunnyvale, CA

#2,190 in California

#9,262 in US

#18,281 in the World

Sunnyvale, CA, United States of America

Hyseq, Inc.

Forward Citations = 2,466

33 inventors:

Radoje Drmanac (16 out of 134 patents)

John E Ford (12 out of 18 patents)

Ann Pace (6 out of 6 patents)

4. Radomir B Crkvenjakov (6 out of 9 patents)

5. George Yeung (5 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hyseq, Inc.. Retrieved from https://idiyas.com/company/hyseq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…